Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Is Alexion Pharmaceuticals a Buy?

TheMotleyFool

0 0

Is Alexion Pharmaceuticals a Buy?Photo, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

There are plenty of promising biotech stocks for investors to sift through right now. One of these companies is Alexion Pharmaceuticals (NASDAQ: ALXN), a developer of treatments for rare diseases that has seen tremendous success with its flagship drug, Soliris.

With management expecting further sales growth, there's a lot of potential upside for this company in the future. At the same time, its shares are trading quite cheaply in comparison to other biotech companies'.

Does that make this stock an automatic buy in 2020? Let's find out.

Source Fool.com

Like: 0

ALXN

Teilen